A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells

Antonella Borrelli, Antonella Schiattarella, Roberto Mancini, Brunello Morrica, Vincenzo Cerciello, Maria Mormile, Valentina d'Alesio, Laura Bottalico, Francesco Morelli, Maria D'Armiento, Francesco Paolo D'Armiento, Aldo Mancini

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Organisms exposed to ionizing radiation are mainly damaged by free radicals, which are generated by the radiolysis of water contained in the cells. Recently a significant reduction of tissue injury from irradiation damage was demonstrated by using MnSOD-plasmid/liposome treatments in the protection of murine lung. In this study we show that a new active recombinant human MnSOD (rMnSOD), easily administered in vivo, not only exerts the same radioprotective effect on normal cells and organisms as any MnSOD, but it is also radiosensitizing for tumor cells. In addition, we show how healthy animals, exposed to lethal doses of ionizing radiation and daily injections with rMnSOD, were protected from radiodamage and were still alive 30 days after the irradiation, while animals treated with only PBS solution, in the absence of rMnSOD, died after 7-8 days from the radiotreatments. The molecular analysis of all irradiated tissues revealed that the antiapoptotic AVEN gene appeared activated only in the animals treated in the presence of rMnSOD. The data suggest that rMnSOD deserves to be considered as a pharmaceutical tool for making radiotherapy more selective on cancer cells and to prevent and/or cure the accidental damage derived from exposure to ionizing radiation.

Original languageEnglish
Pages (from-to)110-116
Number of pages7
JournalFree Radical Biology and Medicine
Volume46
Issue number1
DOIs
Publication statusPublished - Jan 1 2009

Fingerprint

Ionizing radiation
Tumors
Animals
Cells
Ionizing Radiation
Irradiation
Tissue
Neoplasms
Radiolysis
Radiotherapy
Liposomes
Dosimetry
Free Radicals
Plasmids
Genes
Water
Pharmaceutical Preparations
Lung
Injections
Wounds and Injuries

Keywords

  • Cell population
  • Radioprotection
  • Radiosensitizing
  • Viability

ASJC Scopus subject areas

  • Biochemistry
  • Physiology (medical)

Cite this

A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells. / Borrelli, Antonella; Schiattarella, Antonella; Mancini, Roberto; Morrica, Brunello; Cerciello, Vincenzo; Mormile, Maria; d'Alesio, Valentina; Bottalico, Laura; Morelli, Francesco; D'Armiento, Maria; D'Armiento, Francesco Paolo; Mancini, Aldo.

In: Free Radical Biology and Medicine, Vol. 46, No. 1, 01.01.2009, p. 110-116.

Research output: Contribution to journalArticle

Borrelli, A, Schiattarella, A, Mancini, R, Morrica, B, Cerciello, V, Mormile, M, d'Alesio, V, Bottalico, L, Morelli, F, D'Armiento, M, D'Armiento, FP & Mancini, A 2009, 'A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells', Free Radical Biology and Medicine, vol. 46, no. 1, pp. 110-116. https://doi.org/10.1016/j.freeradbiomed.2008.10.030
Borrelli, Antonella ; Schiattarella, Antonella ; Mancini, Roberto ; Morrica, Brunello ; Cerciello, Vincenzo ; Mormile, Maria ; d'Alesio, Valentina ; Bottalico, Laura ; Morelli, Francesco ; D'Armiento, Maria ; D'Armiento, Francesco Paolo ; Mancini, Aldo. / A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells. In: Free Radical Biology and Medicine. 2009 ; Vol. 46, No. 1. pp. 110-116.
@article{d4007ff7d2ea446d8708ebf806846e46,
title = "A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells",
abstract = "Organisms exposed to ionizing radiation are mainly damaged by free radicals, which are generated by the radiolysis of water contained in the cells. Recently a significant reduction of tissue injury from irradiation damage was demonstrated by using MnSOD-plasmid/liposome treatments in the protection of murine lung. In this study we show that a new active recombinant human MnSOD (rMnSOD), easily administered in vivo, not only exerts the same radioprotective effect on normal cells and organisms as any MnSOD, but it is also radiosensitizing for tumor cells. In addition, we show how healthy animals, exposed to lethal doses of ionizing radiation and daily injections with rMnSOD, were protected from radiodamage and were still alive 30 days after the irradiation, while animals treated with only PBS solution, in the absence of rMnSOD, died after 7-8 days from the radiotreatments. The molecular analysis of all irradiated tissues revealed that the antiapoptotic AVEN gene appeared activated only in the animals treated in the presence of rMnSOD. The data suggest that rMnSOD deserves to be considered as a pharmaceutical tool for making radiotherapy more selective on cancer cells and to prevent and/or cure the accidental damage derived from exposure to ionizing radiation.",
keywords = "Cell population, Radioprotection, Radiosensitizing, Viability",
author = "Antonella Borrelli and Antonella Schiattarella and Roberto Mancini and Brunello Morrica and Vincenzo Cerciello and Maria Mormile and Valentina d'Alesio and Laura Bottalico and Francesco Morelli and Maria D'Armiento and D'Armiento, {Francesco Paolo} and Aldo Mancini",
year = "2009",
month = "1",
day = "1",
doi = "10.1016/j.freeradbiomed.2008.10.030",
language = "English",
volume = "46",
pages = "110--116",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - A recombinant MnSOD is radioprotective for normal cells and radiosensitizing for tumor cells

AU - Borrelli, Antonella

AU - Schiattarella, Antonella

AU - Mancini, Roberto

AU - Morrica, Brunello

AU - Cerciello, Vincenzo

AU - Mormile, Maria

AU - d'Alesio, Valentina

AU - Bottalico, Laura

AU - Morelli, Francesco

AU - D'Armiento, Maria

AU - D'Armiento, Francesco Paolo

AU - Mancini, Aldo

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Organisms exposed to ionizing radiation are mainly damaged by free radicals, which are generated by the radiolysis of water contained in the cells. Recently a significant reduction of tissue injury from irradiation damage was demonstrated by using MnSOD-plasmid/liposome treatments in the protection of murine lung. In this study we show that a new active recombinant human MnSOD (rMnSOD), easily administered in vivo, not only exerts the same radioprotective effect on normal cells and organisms as any MnSOD, but it is also radiosensitizing for tumor cells. In addition, we show how healthy animals, exposed to lethal doses of ionizing radiation and daily injections with rMnSOD, were protected from radiodamage and were still alive 30 days after the irradiation, while animals treated with only PBS solution, in the absence of rMnSOD, died after 7-8 days from the radiotreatments. The molecular analysis of all irradiated tissues revealed that the antiapoptotic AVEN gene appeared activated only in the animals treated in the presence of rMnSOD. The data suggest that rMnSOD deserves to be considered as a pharmaceutical tool for making radiotherapy more selective on cancer cells and to prevent and/or cure the accidental damage derived from exposure to ionizing radiation.

AB - Organisms exposed to ionizing radiation are mainly damaged by free radicals, which are generated by the radiolysis of water contained in the cells. Recently a significant reduction of tissue injury from irradiation damage was demonstrated by using MnSOD-plasmid/liposome treatments in the protection of murine lung. In this study we show that a new active recombinant human MnSOD (rMnSOD), easily administered in vivo, not only exerts the same radioprotective effect on normal cells and organisms as any MnSOD, but it is also radiosensitizing for tumor cells. In addition, we show how healthy animals, exposed to lethal doses of ionizing radiation and daily injections with rMnSOD, were protected from radiodamage and were still alive 30 days after the irradiation, while animals treated with only PBS solution, in the absence of rMnSOD, died after 7-8 days from the radiotreatments. The molecular analysis of all irradiated tissues revealed that the antiapoptotic AVEN gene appeared activated only in the animals treated in the presence of rMnSOD. The data suggest that rMnSOD deserves to be considered as a pharmaceutical tool for making radiotherapy more selective on cancer cells and to prevent and/or cure the accidental damage derived from exposure to ionizing radiation.

KW - Cell population

KW - Radioprotection

KW - Radiosensitizing

KW - Viability

UR - http://www.scopus.com/inward/record.url?scp=57649093466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57649093466&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2008.10.030

DO - 10.1016/j.freeradbiomed.2008.10.030

M3 - Article

VL - 46

SP - 110

EP - 116

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

IS - 1

ER -